Cancer.Net Associate Editors share new insights from research presented at the 2019 ASCO Annual Meeting.
ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.
ASCO Annual Meeting 2019: Treatment Advances for Metastatic Prostate Cancer and Pancreatic Cancer, Multiple Myeloma Survival Factors, and Effects of the Affordable Care Act on Cancer Care
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care.
2018-2019 ASCO President Monica M. Bertagnolli, MD, FACS, FASCO, describes how visiting and talking with people with cancer and providers across the United States highlights the importance of access to cancer care.
ASCO Annual Meeting 2019: Immunotherapy for Lung Cancer, Gastrointestinal Cancers and Targeted Therapy for Breast Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer.
Watch a video featuring 2018–2019 ASCO President Monica M. Bertagnolli, MD, FACS, FASCO, discussing the theme for the 2019 ASCO Annual Meeting.
Read research highlights that will be presented at the 2019 ASCO Annual Meeting, covering low-fat diets and risk of breast cancer death, chemotherapy for older adults with esophageal cancer, targeted therapy for those at risk for multiple myeloma, the rate of genetic changes in childhood cancers, and a new targeted therapy for childhood central nervous system tumors.
Improving Outcomes in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Research from the 2018 ASH Annual Meeting
In this podcast, Cancer.Net Associate Editor Dr. Guillermo Garcia-Manero describes MDS and AML research advances presented at the American Society of Hematology Annual Meeting.
Treating Advanced Prostate Cancer and Kidney Cancer: Research from the 2019 Genitourinary Cancers Symposium
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer.
Survivor and advocate Florence Kurttila describes her key takeaways from the 2019 Gastrointestinal Cancers Symposium.